source
- Biotech lobby groups in Washington push to keep Chinese low-cost drug pipeline open amid rising anti-China proposalsWashington biotech lobby groups are working to ensure a steady flow of affordable medicines that originate from Chinese manufacturers. These groups have become aware that they are encountering voc…
- Industry and rare disease groups call for more transparency in FDA voucher pilotThe pharmaceutical industry and rare‑disease advocacy groups have voiced concerns about the Commissioner's National Priority Voucher pilot program. Stakeholders say the program lacks transparency…